Anika Therapeutics ANIK Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Anika Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's current ratio?
- Anika Therapeutics (ANIK) reported current ratio of 4.5× in Q1 2026.
- How has Anika Therapeutics's current ratio changed year-over-year?
- Anika Therapeutics's current ratio decreased by 22.1% year-over-year, from 5.7× to 4.5×.
- What is the long-term trend for Anika Therapeutics's current ratio?
- Over 5 years (2020 to 2025), Anika Therapeutics's current ratio has grown at a -0.4% compound annual growth rate (CAGR), from 4.8× to 4.7×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.